Skip to main content
Premium Trial:

Request an Annual Quote

Sanjiv Sam Gambhir, Jeffrey Gordon, John Niederhuber, Terrence Sejnowski, Deirdre Aubuchon

The National Academies’ Institute of Medicine announced 65 new members this week. Among them are:
  • Sanjiv Sam Gambhir, director of the division of nuclear medicine, and director of the molecular imaging program in the departments of radiology and bioengineering at Stanford University;  
  • Jeffrey Gordon, Robert J. Glaser Distinguished University Professor, and director of the Center for Genome Sciences at Washington University School of Medicine, St. Louis;
  • John Niederhuber, director of the National Cancer Institute; and
  • Terrence Sejnowski, Howard Hughes Medical Institute investigator and Francis Crick Professor at the Salk Institute, and professor of biology and neurosciences at the University of California, San Diego, whose research covers experimental and computational neuroscience.

GenomeQuest named Deirdre Aubuchon chief financial officer of the company.
Aubuchon has over 20 years of experience building technology companies. Aubuchon most recently served as Deploy Solutions' chief financial and operating officer. Kronos acquired the firm, a software-as-a-service provider, in 2007.
Before Deploy, Aubuchon served as vice president of finance for online consulting firm Zefer. Prior to that, she was vice president of corporate finance at Liberty International, where she directed worldwide M&A activity.

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.